ClinicalTrials.gov
ClinicalTrials.gov Menu

The Role of Positron Emission Tomography (PET) During Erlotinib Treatment for Non-small Cell Lung Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01000428
Recruitment Status : Unknown
Verified October 2009 by Asan Medical Center.
Recruitment status was:  Recruiting
First Posted : October 23, 2009
Last Update Posted : October 27, 2009
Sponsor:
Information provided by:
Asan Medical Center

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : May 2010
  Estimated Study Completion Date : December 2011